| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | lapatinib | CCLE | pan-cancer | AAC | 0.2 | 0.001 |
| mRNA | Sorafenib | CCLE | pan-cancer | AAC | -0.16 | 0.01 |
| mRNA | L-685458 | CCLE | pan-cancer | AAC | -0.11 | 0.07 |
| mRNA | LBW242 | CCLE | pan-cancer | AAC | 0.1 | 0.1 |
| mRNA | 17-AAG | CCLE | pan-cancer | AAC | 0.092 | 0.2 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | 0.081 | 0.2 |
| mRNA | TKI258 | CCLE | pan-cancer | AAC | -0.077 | 0.2 |
| mRNA | AEW541 | CCLE | pan-cancer | AAC | 0.076 | 0.2 |
| mRNA | AZD6244 | CCLE | pan-cancer | AAC | -0.07 | 0.2 |
| mRNA | Topotecan | CCLE | pan-cancer | AAC | 0.058 | 0.3 |